United States
This is an Insight article, written by a selected partner as part of WTR's co-published content. Read more on Insight
The drug naming process comprises three components: the chemical name for the molecular structure of a drug, its generic name and its brand name. The reason for having both a generic name and a brand name is because a generic name may be used by all who wish to refer to this substance, whereas a brand name is owned by the firm that markets that drug.
Download
